2015 Pregnancy Summit– State of the science on medicine in pregnancy

The Pregnancy Summit, held in London in early October, was an opportunity to hear about some of the latest science related to pregnancy and fetal health medicine. The Pregnancy and Medicine Initiative was present at the conference, which took place simultaneously with the first European Safe Motherhood Week, to help highlight some of the important work being done to improve…

Read more > 2015 Pregnancy Summit– State of the science on medicine in pregnancy

Cancer and Pregnancy Conference – the case for centralized data and a multidisciplinary approach

Inspired. It’s hard to think of last Thursday’s Cancer and Pregnancy conference, organized by our partner Mummy’s Star, and not have this feeling come back over and over again. Inspired – By the wonderful people who, in the face of adversity and grief, turned one of the most difficult experiences one could ever be confronted with into an opportunity to…

Read more > Cancer and Pregnancy Conference – the case for centralized data and a multidisciplinary approach

Cancer and Pregnancy Awareness Week: Risks of delay in diagnosis can have serious impact

Our partner Mummy’s Star, a UK charity supporting women diagnosed with cancer in and around pregnancy, is launching its second “Cancer and Pregnancy Awareness Week.” Last year’s awareness week helped heighten awareness of how a cancer diagnosis, either in the midst of a pregnancy or soon after a birth, can impact families. This resulted in an uptake of support for…

Read more > Cancer and Pregnancy Awareness Week: Risks of delay in diagnosis can have serious impact

The future of pregnancy and medication

Lode Dewulf has studied and practiced medicine and worked in the pharmaceutical industry for more than 25 years. Outspoken on the rights of pregnant women to receive information and treatment, Dr. Dewulf took part in the recent European Gender Medicine Network (EUGenMed) Sex and Gender conference at the at the European Economic and Social Commission, giving a talk entitled “Safe…

Read more > The future of pregnancy and medication

An interdisciplinary approach to cancer in pregnancy

Dr. Frédéric Amant is at the forefront of cancer and pregnancy research and a member of the Pregnancy and Medicine Initiative advisory board. As part of an international expert panel, Amant meets colleagues from around the world at five-year intervals to discuss the diagnosis and management of cancer in pregnancy. The panel draws on its own professional experience and reviews…

Read more > An interdisciplinary approach to cancer in pregnancy

Is it possible to collect data directly from pregnant women?

The Pregnancy and Medicine Initiative has talked a lot about the data gap around pregnancy and medication. We’ve also highlighted how hard it can be to collect such information. Practical and ethical roadblocks exist which can hinder the gathering of this vital data but it’s crucial that a way around it is found. A large-scale study in Europe is attempting…

Read more > Is it possible to collect data directly from pregnant women?

A decade of cancer and pregnancy research at KU Leuven

Marnix Verley, now four years old, is probably too young to realize it. But when his mother Lesley was pregnant with him, she was diagnosed with breast cancer. His parents faced the difficult choice between terminating the pregnancy and treating the cancer with chemotherapy. Advised by Dr. Frédéric Amant, they opted for treatment, and, after six rounds of chemo, Lesley…

Read more > A decade of cancer and pregnancy research at KU Leuven

Load